Generic placeholder image

Current Angiogenesis (Discontinued)

Editor-in-Chief

ISSN (Print): 2211-5528
ISSN (Online): 2211-5536

Targeting Angiogenesis in the Treatment of Multiple

Author(s): Najib Dally and Elizabeth Eshel

Volume 3, Issue 1, 2014

Page: [39 - 47] Pages: 9

DOI: 10.2174/2211552802666140404003016

Price: $65

Open Access Journals Promotions 2
Abstract

Multiple Myeloma (MM) remains an incurable disease. Scientific understanding of the biology and influence of the microenvironment in disease progression and outcome has led to treatment improvements by targeting angiogenesis. Reviews of the underlying biology and meta-analyses of the clinical data tend to be mutually exclusive. This minireview highlights important data regarding angiogenesis in MM as well as the drugs currently used to target angiogenesis in its treatment.

Keywords: Angiogenesis inhibitors, anti angiogenetic agents, anti-angiogenic effects, immunomodulation, multiple myeloma.

Graphical Abstract

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy